S. Lagoiko

Acute lymphoblastic leukemia in children with Down syndrome: comparative analysis of treatment results according to ALL-MB 2008 and ALL-MB 2015 protocols

N. Myakova, G. Novichkova, A. Popov, 2022, Russian Journal of Pediatric Hematology and Oncology.

Clinical significance of cytogenetic changes in childhood T-cell acute lymphoblastic leukemia: results of the multicenter group Moscow–Berlin (MB)

G. Henze, G. Tallen, O. Bydanov, 2018, Leukemia & lymphoma.

Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience

G. Novichkova, A. Maschan, A. Popov, 2021 .

Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002

G. Henze, J. Boos, A. von Stackelberg, 2019, Journal of Cancer Research and Clinical Oncology.

[Age-related characteristics of the efficacy of different glucocorticosteroids in the therapy of acute lymphoblastic leukemia].

G. Henze, G. Tallen, C. Bührer, 2015, Terapevticheskii arkhiv.

Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002

G. Henze, N. Myakova, G. Tallen, 2015, Leukemia.